INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

INDU.A

329.6

+0.8%↑

INDU.C

330.1

+0.92%↑

AZA

302.3

-4.85%↓

ORES

118.88

+1.16%↑

Search

Biotage AB

Open

140.4 -0.99

Overview

Share price change

24h

Current

Min

140.1

Max

141.6

Key metrics

By Trading Economics

Income

97M

158M

Sales

92M

582M

P/E

Sector Avg

25.507

20.525

EPS

1.416

Dividend yield

1.82

Profit margin

27.148

Employees

680

EBITDA

111M

222M

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.82%

4.36%

Next Earnings

16 Jul 2025

Market Stats

By TradingEconomics

Market Cap

-3.9B

7.2B

Previous open

141.39

Previous close

140.4

Biotage AB Chart

Past performance is not a reliable indicator of future results.

Related News

22 Apr 2025, 06:50 UTC

Acquisitions, Mergers, Takeovers

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

22 Apr 2025, 06:04 UTC

Acquisitions, Mergers, Takeovers

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22 Apr 2025, 06:03 UTC

Acquisitions, Mergers, Takeovers

KKR: Biotage Board Recommends Shareholders Accept Offer

22 Apr 2025, 06:02 UTC

Acquisitions, Mergers, Takeovers

KKR: Offer Values Biotage at SEK11.61B

22 Apr 2025, 06:02 UTC

Acquisitions, Mergers, Takeovers

KKR Makes SEK145 a Share Bid For Biotage

Peer Comparison

Price change

Biotage AB Forecast

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Biotage AB

Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems; sample preparation products; plasmid purification solutions; oligo synthesis solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, diagnostics, clinical, environmental protection, food safety, clinical, forensic, and academic laboratories industries. It operates in more than 80 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.